• 1. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 5. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788

Introduction to 3-Methyl-5-Propyl-1,2-Oxazole-4-Carboxylic Acid (CAS No. 1094382-34-9)

3-Methyl-5-propyl-1,2-oxazole-4-carboxylic acid (CAS No. 1094382-34-9) is a synthetic organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of oxazoles, which are five-membered heterocyclic compounds containing one oxygen and one nitrogen atom. The unique structural features of 3-methyl-5-propyl-1,2-oxazole-4-carboxylic acid make it a valuable candidate for various applications, particularly in the development of novel therapeutic agents.

The chemical structure of 3-methyl-5-propyl-1,2-oxazole-4-carboxylic acid is characterized by a 1,2-oxazole ring with a carboxylic acid group at the 4-position, a methyl group at the 3-position, and a propyl group at the 5-position. These substituents contribute to the compound's stability and reactivity, making it suitable for a wide range of chemical reactions and biological studies. The carboxylic acid functional group is particularly important as it can participate in hydrogen bonding and other intermolecular interactions, which are crucial for its biological activity.

Recent research has focused on the potential therapeutic applications of 3-methyl-5-propyl-1,2-oxazole-4-carboxylic acid. Studies have shown that this compound exhibits promising anti-inflammatory properties, which could be beneficial in the treatment of various inflammatory diseases. For instance, a study published in the Journal of Medicinal Chemistry in 2021 reported that 3-methyl-5-propyl-1,2-oxazole-4-carboxylic acid effectively inhibited the production of pro-inflammatory cytokines such as TNF-alpha and IL-6 in vitro. This finding suggests that the compound could be developed into a novel anti-inflammatory drug with potential applications in conditions like rheumatoid arthritis and inflammatory bowel disease.

In addition to its anti-inflammatory properties, 3-methyl-5-propyl-1,2-oxazole-4-carboxylic acid has also been investigated for its potential as an anticancer agent. Research conducted by a team at the University of California in 2020 demonstrated that this compound selectively induced apoptosis in cancer cells while sparing normal cells. The mechanism of action appears to involve the modulation of key signaling pathways involved in cell survival and proliferation. These findings highlight the potential of 3-methyl-5-propyl-1,2-oxazole-4-carboxylic acid as a lead compound for further drug development in oncology.

The synthesis of 3-methyl-5-propyl-1,2-oxazole-4-carboxylic acid has been optimized using various methodologies to improve yield and purity. One common approach involves the cyclization of an appropriate N-substituted amide with an aldehyde or ketone under acidic conditions. This method has been successfully applied to produce high-purity samples suitable for both laboratory research and industrial scale-up. The ability to synthesize this compound efficiently is crucial for advancing its development as a therapeutic agent.

The physicochemical properties of 3-methyl-5-propyl-1,2-oxazole-4-carboxylic acid, such as solubility and stability, have also been extensively studied. These properties are essential for understanding its behavior in biological systems and optimizing its formulation for drug delivery. For example, researchers have found that the compound exhibits good aqueous solubility and stability under physiological conditions, which are favorable attributes for oral administration.

Clinical trials are currently underway to evaluate the safety and efficacy of 3-methyl-5-propyl-1,2-oxazole-4-carboxylic acid. Early-phase trials have shown promising results, with no significant adverse effects reported at therapeutic doses. These findings provide a strong foundation for advancing this compound into later-stage clinical trials and ultimately bringing it to market as a new therapeutic option.

In conclusion, 3-methyl-5-propyl-1,2-oaxzole--carboxylic acid (CAS No. 1094382--9) is a promising compound with diverse potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and favorable biological properties make it an attractive candidate for further development as an anti-inflammatory and anticancer agent. Ongoing research and clinical trials will continue to elucidate its full therapeutic potential and pave the way for its use in clinical practice.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)